FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
Mon, 19 Oct 2009 16:54:00 -0500
The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix to include children ages 3 years to 17 years. Previously, this vaccine, which contains inactivated (killed) influenza A and B viruses, had been approved for use in adults, ages 18 years and older.
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420